InsidersTradesSigma
Follow the 텔콘RF제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 텔콘RF제약 has logged 33 public disclosures. Market capitalisation: €15.3bn. The latest transaction was filed on 16 July 2026 (Other). Among the most active insiders: 뉴온. Every trade is free.
33
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
13 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,475 of 29,062 companies
9.9
score / 100
Value8
Quality12
FCF yld-22%
Earn yld-43%
EV/EBITDA·
ROE-17%
Gross mgn8.6%
Net mgn-10%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations33 total
2,329,916 sharesKRXDART:20260716000738
2,989,916 sharesShareKRXDART:20260716000723
25 of 33 declarations
Acerca de 텔콘RF제약
텔콘RF제약 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de productos farmacéuticos innovadores.